Absence of clinical symptoms following the first injection of anti-T cell receptor monoclonal antibody (BMA 031) despite isolated TNF release.
Chatenoud
L
L
INSERM U 25 and Transplantation Unit, Hôpital Necker, Paris, France.
Legendre
C
C
Kurrle
R
R
Kreis
H
H
Bach
J F
JF
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D051379:Mice; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D011948:Receptors, Antigen, T-Cell; D014409:Tumor Necrosis Factor-alpha